| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $305.3M | +1.7% | +9.2% |
| Cost of Revenue | $134.8M | +0.7% | +7.0% |
| Gross Profit | $170.5M | +2.5% | +10.9% |
| R&D Expense | $39.7M | +9.9% | -3.5% |
| SG&A Expense | $32.9M | -3.0% | -6.6% |
| Operating Income | $18.5M | -6.6% | +440.7% |
| Pre-tax Income | $20.6M | -10.7% | +2605.7% |
| Income Tax | $2.2M | -35.2% | +1069.0% |
| Net Income | $18.4M | -6.6% | +3096.5% |
| EPS (Basic) | $0.24 | -4.0% | +2300.0% |
| EPS (Diluted) | $0.21 | -8.7% | +2000.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $273.0M | +17.6% | -26.3% |
| Accounts Receivable | $136.5M | +4.2% | +15.1% |
| Current Assets | $1.01B | +4.8% | -21.9% |
| Total Assets | $1.87B | +4.2% | -10.7% |
| Current Liabilities | $222.8M | +4.6% | -65.1% |
| Total Liabilities | $1.04B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $63.9M | — | +32.1% |
| Capital Expenditures | $5.3M | — | +11.5% |
| Investing Cash Flow | -$146K | — | +99.6% |
| Financing Cash Flow | -$22.8M | — | -955.4% |
| Free Cash Flow | $58.7M | — | +34.3% |
| -27.4% |
| Stockholders' Equity | $829.6M | +5.6% | +24.9% |